T · 3341.T
NIHON CHOUZAI Co.,Ltd.
- Sector
- Healthcare · Medical - Pharmaceuticals
- Headquarters
- Tokyo 100-6737
- Website
- nicho.co.jp
Price · as of 2025-03-31
$3,910.00
Market cap 116.82B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $3,869.24 | -1.04% |
| Intrinsic Value(DCF) | $2,075.63 | -46.91% |
| Graham-Dodd Method(GD) | $1,446.26 | -63.01% |
| Graham Formula(GF) | $645.43 | -83.49% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $548.55 | $616.21 | $9,744.46 | $251.02 | $1,385.13 |
| 2012 | $576.58 | $788.87 | $22,562.05 | $347.46 | $1,704.39 |
| 2013 | $526.92 | $907.86 | $4,344.81 | $12.25 | $95.89 |
| 2014 | $556.85 | $991.20 | $21,431.05 | $293.27 | $1,700.39 |
| 2015 | $1,293.64 | $1,750.94 | $9,741.22 | $535.70 | $1,720.76 |
| 2016 | $2,037.70 | $2,472.81 | $53,535.14 | $1,632.74 | $6,023.60 |
| 2017 | $1,585.39 | $2,034.77 | $1,863.30 | $1,031.64 | $1,456.22 |
| 2018 | $1,340.22 | $2,600.90 | $737.02 | $1,394.93 | $3,011.66 |
| 2019 | $1,628.15 | $2,263.88 | $586.41 | $1,079.27 | $1,199.32 |
| 2020 | $1,486.16 | $2,795.96 | $899.63 | $1,745.02 | $3,781.08 |
| 2021 | $1,490.80 | $1,960.72 | $962.09 | $1,327.71 | $1,388.11 |
| 2022 | $1,173.81 | $2,226.76 | $1,056.46 | $1,498.85 | $1,879.09 |
| 2023 | $1,106.76 | $2,319.79 | $1,078.87 | $1,781.64 | $1,865.73 |
| 2024 | $1,379.36 | $2,386.17 | $1,274.46 | $1,568.54 | $1,395.80 |
| 2025 | $3,270.00 | $3,869.24 | $1,196.91 | $1,446.26 | $645.43 |
AI valuation
Our deep-learning model estimates NIHON CHOUZAI Co.,Ltd.'s (3341.T) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $3,869.24
- Current price
- $3,910.00
- AI upside
- -1.04%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$2,075.63
-46.91% upside
Graham-Dodd
$1,446.26
-63.01% upside
Graham Formula
$645.43
-83.49% upside
About NIHON CHOUZAI Co.,Ltd.
Nihon Chouzai Co., Ltd. engages in the management of health insurance dispensing chain pharmacies in Japan. The company also manufactures and sells generic drugs to medical institutions and other pharmacies. In addition, it offers temporary staffing services for pharmacist; and employment services for physicians and registered sales personnel, and other healthcare professionals. Further, the company provides studies and research services for pharmaceutical companies and organizations; information and consulting services for industries associated with pharmaceuticals and healthcare; and other services. As of March 31, 2022, it had 697 stores. The company was incorporated in 1980 and is headquartered in Tokyo, Japan.
- CEO
- Kazunori Ogi
- Employees
- 5.86K
- Beta
- 0.41
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2,075.63 ÷ $3,910.00) − 1 = -46.91% (DCF, example).